Vitas
Born | February 19, 1979 |
Hometown | Daugavpils, Latvia |
Net worth | $20 million |
Height | 5'10" (1.79m) |
Spouse | Svetlana Grankovskaya (m 2006 - present) |
Children | Alla Grachov |
Top Stories
Chemed (CHE) Q4 Earnings Beat Estimates, Margins Contract
- Chemed (CHE) reports impressive sales growth in the Roto-Rooter subsidiary in the fourth quarter of 2022.
More Stories
- BusinessZacks
Here's Why You Should Hold on to Chemed (CHE) Stock Now
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and impressive Roto-Rooter results.
Thanks for your feedback! - BusinessZacks
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Thanks for your feedback! - BusinessZacks
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Thanks for your feedback! - BusinessZacks
Here's Why You Should Hold on to Chemed (CHE) Stock For Now
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
Thanks for your feedback! - BusinessZacks
Chemed (CHE) Roto-Rooter Sales Robust Despite COVID-19 Woes
Chemed's (CHE) Roto-Rooter business gains from growing demand for plumbing, drain cleaning and excavation and water restoration services.
Thanks for your feedback! - BusinessZacks
Here's Why You Should Add Chemed (CHE) to Your Portfolio Now
Investors are optimistic about Chemed (CHE) on strong third-quarter performance and raised Roto-Rooter and earnings guidance for 2021.
Thanks for your feedback! - BusinessZacks
Chemed (CHE) Q3 Earnings Beat Estimates, Full-Year EPS View Up
Chemed (CHE) reports better-than-expected earnings and revenues in the third-quarter 2021, with a solid performance by the Roto-Rooter segment driving the top line.
Thanks for your feedback! - BusinessZacks
Chemed (CHE) Up 1.9% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thanks for your feedback! - BusinessZacks
Why Is Chemed (CHE) Down 2.6% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thanks for your feedback! - BusinessBenzinga
Recap: Chemed Q4 Earnings
Shares of Chemed (NYSE:CHE) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 21.56% over the past year to $5.13, which were in line with the estimate of $5.13. Revenue of $533,289,000 rose by 2.10% year over year, which missed the estimate of $537,200,000. Guidance The upcoming fiscal year's EPS expected to be between $17.00 and $17.50. View more earnings on CHE Chemed hasn't issued any revenue guidance for the time being. Technic
Thanks for your feedback!